Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study Comparing Efficacy and Safety of " Treat-and-Extend" Regimen Versus "Pro Re Nata" Regimen of Conbercept in Neovascular Age-related Macular Degeneration

NCT02802657 is registered in ClinicalTrials.gov with Xiaodong Sun as lead sponsor.

NCT NCT02802657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02802657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study Comparing Efficacy and Safety of " Treat-and-Extend" Regimen Versus "Pro Re Nata" Regimen of Conbercept in Neovascular Age-related Macular Degeneration
Lead sponsor
Xiaodong Sun
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2020
Enrollment
141 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration